похоже, где-то оне (тестостерон с эритропоэтином) воздействуют на одни и те же рецепторы, раз назначение э-поэтина было замечено в повышении либидо:
Improved sexual function during recombinant human erythropoietin therapy.
Bommer J, Kugel M, Schwöbel B, Ritz E, Barth HP, Seelig R.
Nephrol Dial Transplant. 1990;5(3):204-7.
---
In men, the treatment with rhERP brought about libido elevation in the absence of significant alterations in the blood gonadotrophin and testosterone concentrations...
Ter Arkh. 1991;63(6):81-6.
[The effect of treatment with human recombinant erythropoietin on the functional status of patients on maintenance hemodialysis].
[Article in Russian]
Ermolenko VM, Lashutin SV, Rudakov AG, Fel'd BN, Manakova TE, Kukhtevich AV, Kondakhchan MA, Romanenko NG.
---
During first 4 months of the therapy there was a significant increase of Ht (21.1 +/- 0.5% vs 28.5 +/- 0.6%; p < 0.0001), which was maintained for the whole study period. From the 3rd month in majority of patients a marked (p < 0.01) improvement in their physical fitness, mood and cold tolerance was noted. Despite a substantial increase in sexual satisfaction (p < 0.01) and libido (p < 0.001), no significant changes in serum sex hormones profile, except transient rise in serum prolactin level, were observed. It is concluded that low-dose rHuEpo therapy for the renal anemia of hemodialysis patients is associated with a sustained significant improvement in their quality of life and sexual functions, despite no significant changes in sex hormones serum levels.
Pol Arch Med Wewn. 1996 Aug;96(2):143-52.
[Effect of low-dose recombinant humane erythropoietin therapy on the quality of life in patients with anemia in the course of end-stage renal failure treated with dialysis].
[Article in Polish]
Matuszkiewicz-Rowińska J, Marusza W, Andrzejewski A, Goliat E, Pacocha E, Switalski M, Zawadzka M, Ostrowski K.
|